Analyst Updates: Sept 24, 2026

Analyst Ratings:

The latest 340 Canadian and US analyst updates suggest a selective market outlook. Target cuts across asset management, gold mining, real estate, banking, restaurants and consumer businesses point to more cautious earnings and valuation expectations, even where positive ratings remain. At the same time, higher targets in technology, software, transportation and selected smaller companies show that analysts still see opportunities for growth. Overall, the ratings favour stock selection over a broad market rally, with investors likely to focus on companies that can support their valuations through stronger results.

Canadian Analyst Ratings

AGF Management Ltd. (AGF.B:CA) — TD Securities lowered its price target to $20.00 from $23.00 and maintained a Buy rating.

AGF Management Ltd. (AGF.B:CA) — BMO lowered its price target to $19.00 from $21.00; no rating was provided.

AGF Management Ltd. (AGF.B:CA) — Desjardins Securities lowered its price target to $21.00 from $23.00 and maintained a Buy rating.

AGF Management Ltd. (AGF.B:CA) — RBC Capital lowered its price target to $20.00 from $23.00 and maintained a Sector Perform rating.

BlackBerry Limited (BB:CA) — CIBC lowered its price target to $18.00 and maintained an Outperform rating; the previous target was not provided.

Cameco Corp. (CCO:CA) — RBC Capital maintained an Outperform rating and a $184.00 price target.

Cameco Corp. (CCO:CA) — TD Securities maintained a Buy rating and a $190.00 price target.

Canadian National Railway Co. (CNR:CA) — RBC Capital lowered its price target to $198.00 from $205.00 and maintained an Outperform rating.

Canadian National Railway Co. (CNR:CA) — CIBC maintained an Outperform rating and a $198.00 price target.

Canadian Pacific Kansas City Ltd. (CP:CA) — RBC Capital raised its price target to $146.00 from $145.00 and maintained an Outperform rating.

Dexterra Group Inc. (DXT:CA) — Raymond James raised its price target to $20.00 from $18.50 and maintained an Outperform rating.

Gildan Activewear Inc. (GIL:CA) — TD Securities lowered its price target to $76.00 from $113.00 and maintained a Buy rating.

Ivanhoe Electric Inc. (IE:CA) — Raymond James lowered its price target to $20.00 from $21.00 and maintained an Outperform rating.

Kinross Gold Corp. (K:CA) — Desjardins Securities lowered its price target to $53.00 from $58.00 and maintained a Buy rating.

Kinross Gold Corp. (K:CA) — Scotiabank lowered its price target to $55.00 from $58.00 and maintained a Sector Outperform rating.

Kinross Gold Corp. (K:CA) — Canaccord Genuity lowered its price target to $66.50 from $73.50 and maintained a Buy rating.

Kinross Gold Corp. (K:CA) — BMO lowered its price target to $48.00 from $49.00 and maintained an Outperform rating.

Kinross Gold Corp. (K:CA) — TD Securities lowered its price target to $49.50 from $56.50 and maintained a Buy rating.

Orezone Gold Corp. (ORE:CA) — National Bank raised its price target to $4.25 from $4.00 and maintained an Outperform rating.

Slate Grocery REIT (SGR.U:CA) — ATB Cormark lowered its price target to $8.00 from $13.00 and maintained an Underperform rating.

Slate Grocery REIT (SGR.U:CA) — CIBC lowered its price target to $8.25 from $12.00 and maintained a Neutral rating.

Stingray Group Inc. (RAY:CA) — CIBC maintained an Outperform rating and a $19.00 price target.

Thinkific Labs Inc. (THNC:CA) — ATB Cormark raised its price target to $3.25 from $2.25 and maintained an Outperform rating.

Total Energy Services Inc. (TOT:CA) — RBC Capital initiated coverage with a Sector Perform rating and a $41.00 price target.

Total Energy Services Inc. (TOT:CA) — ATB Cormark raised its price target to $42.00 from $36.50 and maintained an Outperform rating.

US Analyst Ratings

3M (MMM) — Wells Fargo & Company set a price target of $195.00 for the stock.

Aardvark Therapeutics (AARD) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $6.00.

AbCellera Biologics (ABCL) — Goldman initiated coverage of the company with a Neutral rating and a price target of $13.

AC Immune (ACIU) — HC Wainwright reiterated its Buy rating on the stock.

ACADIA Pharmaceuticals (ACAD) — BMO Capital Markets reiterated its Outperform rating on the stock.

ACADIA Pharmaceuticals (ACAD) — Citigroup lowered its price target for the stock to $33.00 from $40.00 while maintaining a Buy rating.

ACADIA Pharmaceuticals (ACAD) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $41.00.

ACADIA Pharmaceuticals (ACAD) — TD Cowen reiterated its Buy rating on the stock.

Afya (AFYA) — Bradesco Corretora upgraded the stock to Outperform and set a price target of $17.00.

Alexandria RE (ARE) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $56.

Alexandria Real Estate Equities (ARE) — Jefferies Financial Group lowered its price target for the stock to $46.00 from $47.00 while maintaining a Hold rating.

Alight (ALIT) — DA Davidson lowered its price target for the stock to $22.00 from $32.00 while maintaining a Buy rating.

Alkami Technology (ALKT) — Citigroup reiterated its Market Outperform rating on the stock.

Alkami Technology (ALKT) — Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $24.00.

Alkami Technology (ALKT) — JP Morgan downgraded the stock from Overweight to Underweight and lowered its price target to $14.00 from $24.00.

Alkermes (ALKS) — The Goldman Sachs Group reiterated its Neutral rating on the stock with a price target of $50.00.

Almonty Industries (ALM) — The Goldman Sachs Group initiated coverage of the company with a Neutral rating and a price target of $13.00.

Americold Realty Trust (COLD) — JP Morgan upgraded the stock from Underweight to Neutral and set a price target of $16.

Angi (ANGI) — UBS Group set a price target of $14.00 for the stock.

Anheuser-Busch InBev SA/NV (BUD) — Bank of America reiterated its Buy rating on the stock.

Anheuser-Busch InBev SA/NV (BUD) — Deutsche Bank Aktiengesellschaft reiterated its Buy rating on the stock.

Anheuser-Busch InBev SA/NV (BUD) — Jefferies Financial Group reiterated its Buy rating on the stock.

Anheuser-Busch InBev SA/NV (BUD) — JPMorgan Chase & Co. reiterated its Buy rating on the stock.

Anheuser-Busch InBev SA/NV (BUD) — UBS Group reiterated its Buy rating on the stock.

Arcturus Therapeutics (ARCT) — BTIG Research lowered its price target for the stock to $20.00 from $23.00 while maintaining a Buy rating.

Arcturus Therapeutics (ARCT) — Cantor Fitzgerald reiterated its Overweight rating on the stock.

Arcturus Therapeutics (ARCT) — Citigroup upgraded the stock from Neutral to Buy and raised its price target to $20.00 from $8.00.

Ares Management (ARES) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $150.

Arrowhead (ARWR) — Goldman resumed coverage of the company with a Neutral rating and a price target of $74.

Arthur J. Gallagher & Co. (AJG) — Cantor Fitzgerald reiterated its Neutral rating on the stock.

Arthur J. Gallagher & Co. (AJG) — Keefe, Bruyette & Woods reiterated its Market Perform rating on the stock.

Arthur J. Gallagher & Co. (AJG) — Piper Sandler reiterated its Overweight rating on the stock.

Arthur J. Gallagher & Co. (AJG) — Royal Bank Of Canada lowered its price target for the stock to $290.00 from $310.00 while maintaining a Outperform rating.

Arthur J. Gallagher & Co. (AJG) — Wells Fargo & Company lowered its price target for the stock to $291.00 from $296.00 while maintaining a Overweight rating.

Aurora Innovation (AUR) — Canaccord Genuity Group raised its price target for the stock to $17.00 from $15.00 while maintaining a Buy rating.

Aurora Innovation (AUR) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $13.00.

Aurora Innovation (AUR) — The Goldman Sachs Group raised its price target for the stock to $7.00 from $6.00 while maintaining a Neutral rating.

Autodesk (ADSK) — UBS Group reiterated its Buy rating on the stock.

Bank of America (BAC) — Jefferies Financial Group lowered its price target for the stock to $70.00 from $75.00 while maintaining a Buy rating.

Beta Bionics (BBNX) — Truist Financial raised its price target for the stock to $28.00 from $23.00 while maintaining a Buy rating.

Blue Owl Capital (OWL) — Citigroup reiterated its Market Outperform rating on the stock.

Blue Owl Capital (OWL) — HSBC set a price target of $17.00 for the stock.

BlueLinx (BXC) — Citigroup initiated coverage of the company with a Market Perform rating.

BlueLinx (BXC) — Citizens initiated coverage of the company with a Market Perform rating.

BMW Group (BMWKY) — HSBC Securities downgraded the stock from Buy to Hold.

Booking (BKNG) — BTIG Research reiterated its Buy rating on the stock with a price target of $250.00.

Booking (BKNG) — Citigroup reiterated its Market Perform rating on the stock.

Brixmor Property Group (BRX) — Mizuho lowered its price target for the stock to $30.00 from $33.00 while maintaining a Outperform rating.

BWX Technologies (BWXT) — BNP Paribas Exane lowered its price target for the stock to $165.00 from $190.00 while maintaining a Neutral rating.

Cal-Maine Foods (CALM) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $75.00 from $83.00.

Canadian Pacific Kansas City (CP) — Royal Bank Of Canada reiterated its Outperform rating on the stock.

CareDx (CDNA) — BTIG Research raised its price target for the stock to $74.00 from $60.00 while maintaining a Buy rating.

Carlyle Group (CG) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $54.

Carnival (CCL) — JPMorgan Chase & Co. lowered its price target for the stock to $39.00 from $43.00 while maintaining a Overweight rating.

Carnival (CCL) — Susquehanna lowered its price target for the stock to $28.00 from $33.00 while maintaining a Positive rating.

Carrier Global (CARR) — Wells Fargo & Company set a price target of $67.00 for the stock and changed its rating from Negative to Overweight.

Cinemark (CNK) — Morgan Stanley lowered its price target for the stock to $40.00 from $42.00 while maintaining a Equal Weight rating.

Cintas (CTAS) — Robert W. Baird changed its price target for the stock to $222.00 from $214.00 with an Outperform rating.

Cintas (CTAS) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $206.00.

Cintas (CTAS) — Truist Financial raised its price target for the stock to $230.00 from $225.00 while maintaining a Buy rating.

Cintas (CTAS) — UBS Group reiterated its Buy rating on the stock and raised its price target to $235.00 from $230.00.

CNB Financial (CCNE) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $38.

Colliers International Group (CIGI) — BMO Capital Markets reiterated its Outperform rating on the stock.

Comcast (CMCSA) — Citigroup lowered its price target for the stock to $27.50 from $30.00 while maintaining a Buy rating.

Comcast (CMCSA) — KeyCorp downgraded the stock from Sector Weight to Underweight and set a price target of $18.00.

CoreWeave (CRWV) — JP Morgan upgraded the stock from Neutral to Overweight and raised its price target to $125.00 from $120.00.

Corteva (CTVA) — Oppenheimer reiterated its Outperform rating on the stock with a price target of $95.00.

Cracker Barrel Old Country Store (CBRL) — Bank of America reiterated its Underperform rating on the stock with a price target of $48.00.

CSX (CSX) — Royal Bank Of Canada lowered its price target for the stock to $53.00 from $54.00 while maintaining a Outperform rating.

Cummins (CMI) — Bank of America lowered its price target for the stock to $600.00 from $731.00.

Darden Restaurants (DRI) — TD Cowen reiterated its Hold rating on the stock with a price target of $215.00.

Deere & Company (DE) — Bank of America raised its price target for the stock to $715.00 from $667.00.

Delta Air Lines (DAL) — UBS Group raised its price target for the stock to $105.00 from $99.00 while maintaining a Buy rating.

Dollar General (DG) — HSBC Securities upgraded the stock from Hold to Buy and raised its price target to $160.00 from $125.00.

Dover (DOV) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $229.00.

DraftKings (DKNG) — Citizens reiterated its Market Outperform rating on the stock and lowered its price target to $35 from $37.

Dropbox (DBX) — Citigroup downgraded the stock from Neutral to Sell and lowered its price target to $29.00 from $33.00.

Dycom Industries (DY) — Cantor Fitzgerald reiterated its Overweight rating on the stock with a price target of $476.00.

Dynatrace (DT) — Oppenheimer reiterated its Outperform rating on the stock and raised its price target to $71 from $60.

EastGroup (EGP) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $231.

Eaton (ETN) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $503.00.

eBay (EBAY) — Arete Research lowered its price target for the stock to $111.00 from $113.00 while maintaining a Neutral rating.

Edison International (EIX) — UBS Group reiterated its Neutral rating on the stock with a price target of $57.00.

Elicio Therapeutics (ELTX) — B. Riley Financial set a price target of $8.00 for the stock while maintaining a Buy rating.

Energy Services of America (ESOA) — Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.

Entera Bio (ENTX) — Guggenheim initiated coverage of the company with a Buy rating.

Essential Properties Realty Trust (EPRT) — Scotiabank lowered its price target for the stock to $30.00 from $33.00 while maintaining a Sector Outperform rating.

Ethos Technologies Inc. Class A Common Stock (LIFE) — Bank of America reiterated its Buy rating on the stock with a price target of $38.00.

Etsy (ETSY) — Arete downgraded the stock from Buy to Neutral and set a price target of $81.

Etsy (ETSY) — Arete Research set a price target of $81.00 for the stock and changed its rating from Buy to Neutral.

Eupraxia Pharmaceuticals (EPRX) — Stifel Nicolaus set a price target of $25.00 for the stock.

Eupraxia Pharmaceuticals (EPRX) — Wedbush initiated coverage of the company with an Outperform rating and a price target of $17.

Everpure (P) — Citigroup raised its price target for the stock to $160.00 from $130.00 while maintaining a Buy rating.

Everpure (P) — Evercore reiterated its Outperform rating on the stock with a price target of $145.00.

Everpure (P) — Guggenheim reiterated its Buy rating on the stock with a price target of $150.00.

Everpure (P) — Lake Street Capital raised its price target for the stock to $130.00 from $120.00 while maintaining a Buy rating.

Everpure (P) — Morgan Stanley raised its price target for the stock to $137.00 from $119.00 while maintaining a Overweight rating.

Everpure (P) — Needham & Company LLC raised its price target for the stock to $150.00 from $140.00 while maintaining a Buy rating.

Everpure (P) — Northland Securities set a price target of $167.00 for the stock.

Everpure (P) — Piper Sandler raised its price target for the stock to $162.00 from $133.00 while maintaining a Overweight rating.

Everpure (P) — Wedbush reiterated its Outperform rating on the stock with a price target of $130.00.

Everpure (P) — Wells Fargo & Company raised its price target for the stock to $145.00 from $135.00 while maintaining a Overweight rating.

Federal Realty Investment Trust (FRT) — Mizuho lowered its price target for the stock to $117.00 from $130.00 while maintaining a Outperform rating.

Federal Realty Investment Trust (FRT) — UBS Group set a price target of $117.00 for the stock.

Fervo Energy (FRVO) — Johnson Rice initiated coverage of the company with a Buy rating and a price target of $35.

Fervo Energy (FRVO) — Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $47.00.

Fifth Third Bancorp (FITB) — Jefferies Financial Group lowered its price target for the stock to $65.00 from $70.00 while maintaining a Buy rating.

First Financial Bancorp. (FFBC) — Truist Financial set a price target of $37.00 for the stock and changed its rating from Hold to Buy.

Forgent Power Solutions (FPS) — Wells Fargo & Company set a price target of $44.00 for the stock.

Frontier Group (ULCC) — UBS Group lowered its price target for the stock to $6.00 from $7.00 while maintaining a Neutral rating.

FuelCell Energy (FCEL) — Barclays initiated coverage of the company with an Equal Weight rating and a price target of $20.

Gaming and Leisure Properties (GLPI) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $46.

Gaming and Leisure Properties (GLPI) — Scotiabank lowered its price target for the stock to $43.00 from $49.00 while maintaining a Sector Perform rating.

General Mills (GIS) — Bank of America reiterated its Neutral rating on the stock.

General Mills (GIS) — Deutsche Bank reiterated its Hold rating on the stock and raised its price target to $34 from $33.

General Mills (GIS) — Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock and raised its price target to $34.00 from $33.00.

General Mills (GIS) — Piper Sandler reiterated its Overweight rating on the stock.

General Mills (GIS) — Sanford C. Bernstein reiterated its Underperform rating on the stock with a price target of $30.00.

General Mills (GIS) — TD Cowen reiterated its Hold rating on the stock and raised its price target to $33 from $32.

General Motors (GM) — TD Cowen reiterated its Hold rating on the stock.

General Motors (GM) — UBS Group set a price target of $33.00 for the stock.

Getty Realty (GTY) — KeyCorp reiterated its Overweight rating on the stock with a price target of $36.00.

Gildan Activewear (GIL) — TD lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.

Gildan Activewear (GIL) — TD Securities lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.

Global Payments (GPN) — Loop Capital initiated coverage of the company with a Buy rating and a price target of $137.00.

Golar LNG (GLNG) — BTIG Research raised its price target for the stock to $75.00 from $70.00 while maintaining a Buy rating.

GRAIL (GRAL) — TD Cowen reiterated its Buy rating on the stock.

Harmony Biosciences (HRMY) — Oppenheimer reiterated its Outperform rating on the stock.

Hubbell (HUBB) — Wells Fargo & Company set a price target of $531.00 for the stock.

Huntington Bancshares (HBAN) — Jefferies Financial Group lowered its price target for the stock to $17.00 from $18.00 while maintaining a Hold rating.

IMAX (IMAX) — Morgan Stanley initiated coverage of the company with an Overweight rating and a price target of $63.

Immunovant (IMVT) — Citigroup reiterated its Positive rating on the stock.

Immunovant (IMVT) — HC Wainwright reiterated its Buy rating on the stock.

Insmed (INSM) — Goldman resumed coverage of the company with a Buy rating and a price target of $188.

Intel (INTC) — TD Cowen reiterated its Hold rating on the stock with a price target of $115.00.

International Paper (IP) — Argus reiterated its Buy rating on the stock with a price target of $45.00.

Intuit (INTU) — The Goldman Sachs Group reiterated its Sell rating on the stock.

Ionis Pharmaceuticals (IONS) — HC Wainwright reiterated its Buy rating on the stock with a price target of $100.00.

Ionis Pharmaceuticals (IONS) — Oppenheimer reiterated its Outperform rating on the stock with a price target of $85.00.

Iovance Biotherapeutics (IOVA) — Goldman resumed coverage of the company with a Buy rating and a price target of $15.

Jazz Pharma (JAZZ) — Goldman resumed coverage of the company with a Buy rating and a price target of $337.

JBT Marel (JBTM) — Robert W. Baird lowered its price target for the stock to $171.00 from $188.00 while maintaining a Outperform rating.

Johnson Controls International (JCI) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $186.00.

JPMorgan Chase & Co. (JPM) — Jefferies Financial Group lowered its price target for the stock to $365.00 from $370.00 while maintaining a Hold rating.

KeyCorp (KEY) — Jefferies Financial Group lowered its price target for the stock to $22.00 from $24.00 while maintaining a Hold rating.

Kimco Realty (KIM) — Mizuho lowered its price target for the stock to $23.00 from $25.00 while maintaining a Neutral rating.

Kimco Realty (KIM) — UBS Group set a price target of $23.00 for the stock.

Kinross Gold (KGC) — Canaccord Genuity Group lowered its price target for the stock to $47.00 from $52.00 while maintaining a Buy rating.

Kinross Gold (KGC) — Scotia lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.

Kinross Gold (KGC) — Scotiabank lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.

Kinross Gold (KGC) — TD lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.

Kinross Gold (KGC) — TD Securities lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.

Kite Realty (KRG) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $27.

Knife River (KNF) — Oppenheimer lowered its price target for the stock to $80.00 from $90.00 while maintaining a Outperform rating.

Kodiak Sciences (KOD) — Goldman resumed coverage of the company with a Neutral rating and a price target of $36.

Kraft Heinz (KHC) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $32.00.

Krystal Biotech (KRYS) — Goldman resumed coverage of the company with a Buy rating and a price target of $441.

Ligand Pharmaceuticals (LGND) — HC Wainwright reiterated its Buy rating on the stock with a price target of $358.00.

Lindsay (LNN) — Stifel Nicolaus set a price target of $121.00 for the stock.

Lowe’s (LOW) — Gordon Haskett downgraded the stock from Buy to Hold and set a price target of $200.

Lumexa Imaging (LMRI) — KeyCorp initiated coverage of the company with an Overweight rating and a price target of $18.00.

LuxExperience B.V. (LUXE) — TD Cowen raised its price target for the stock to $11.00 from $9.00 while maintaining a Buy rating.

M&T Bank (MTB) — Jefferies Financial Group lowered its price target for the stock to $275.00 from $300.00 while maintaining a Buy rating.

Macerich (MAC) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $26.

Madrigal Pharmaceuticals (MDGL) — Goldman resumed coverage of the company with a Buy rating and a price target of $704.

Maze Therapeutics (MAZE) — HC Wainwright reiterated its Buy rating on the stock with a price target of $110.00.

McDonald’s (MCD) — BMO Capital Markets reiterated its Outperform rating on the stock and lowered its price target to $310 from $335.

McDonald’s (MCD) — BTIG Research reiterated its Buy rating on the stock and lowered its price target to $295 from $350.

McDonald’s (MCD) — Evercore ISI reiterated its Outperform rating on the stock and lowered its price target to $300 from $320.

McDonald’s (MCD) — Jefferies Financial Group reiterated its Buy rating on the stock with a price target of $325.00.

McDonald’s (MCD) — JP Morgan reiterated its Overweight rating on the stock and lowered its price target to $260 from $280.

McDonald’s (MCD) — Oppenheimer reiterated its Outperform rating on the stock and lowered its price target to $295 from $325.

McDonald’s (MCD) — RBC Capital Mkts reiterated its Sector Perform rating on the stock and lowered its price target to $285 from $290.

McDonald’s (MCD) — Robert W. Baird reiterated its Neutral rating on the stock and lowered its price target to $250 from $285.

McDonald’s (MCD) — TD Cowen lowered its price target for the stock to $270.00 from $282.00 while maintaining a Hold rating.

McDonald’s (MCD) — UBS Group set a price target of $260.00 for the stock.

MediWound (MDWD) — TD Cowen reiterated its Buy rating on the stock.

MeiraGTx (MGTX) — Goldman initiated coverage of the company with a Neutral rating and a price target of $16.

Mesoblast (MESO) — Cantor Fitzgerald reiterated its Overweight rating on the stock.

Meta Platforms (META) — Citigroup reiterated its Outperform rating on the stock.

Meta Platforms (META) — Citizens Jmp raised its price target for the stock to $885.00 from $770.00 while maintaining a Market Outperform rating.

Meta Platforms (META) — JPMorgan Chase & Co. raised its price target for the stock to $920.00 from $820.00 while maintaining a Overweight rating.

Meta Platforms (META) — Loop Capital raised its price target for the stock to $955.00 from $740.00 while maintaining a Buy rating.

Meta Platforms (META) — Raymond James Financial raised its price target for the stock to $860.00 from $650.00 while maintaining a Strong-Buy rating.

Meta Platforms (META) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $770.00.

Meta Platforms (META) — President Capital upgraded the stock from Neutral to Buy and raised its price target to $897.00 from $660.00.

Meta Platforms (META) — Tigress Financial raised its price target for the stock to $995.00 from $945.00 while maintaining a Strong-Buy rating.

MGE Energy (MGEE) — BofA Securities initiated coverage of the company with a Neutral rating and a price target of $76.

MGM Resorts International (MGM) — Mizuho lowered its price target for the stock to $55.00 from $60.00 while maintaining a Outperform rating.

MGM Resorts International (MGM) — Susquehanna lowered its price target for the stock to $46.00 from $55.00 while maintaining a Positive rating.

MGM Resorts (MGM) — BofA Securities resumed coverage of the company with a Neutral rating and a price target of $40.

Micron Technology (MU) — Rosenblatt Securities reiterated its Buy rating on the stock with a price target of $1,500.00.

MiniMed Group (MMED) — Truist Financial initiated coverage of the company with a Buy rating and a price target of $29.00.

MiniMed (MMED) — Truist initiated coverage of the company with a Buy rating and a price target of $29.

MongoDB (MDB) — Evercore reiterated its Outperform rating on the stock.

Nebius Group N.V. (NBIS) — BNP Paribas Exane upgraded the stock from Neutral to Outperform and raised its price target to $399.00 from $260.00.

NeOnc Technologies Holdings (NTHI) — Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.

NeoVolta (NEOV) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $8.00.

NETSTREIT (NTST) — Scotiabank lowered its price target for the stock to $20.00 from $22.00 while maintaining a Sector Outperform rating.

Newmark Group (NMRK) — Keefe, Bruyette & Woods reiterated its Outperform rating on the stock.

NiCE (NICE) — Royal Bank Of Canada raised its price target for the stock to $145.00 from $130.00 while maintaining a Outperform rating.

Norfolk Southern (NSC) — Royal Bank Of Canada lowered its price target for the stock to $330.00 from $360.00 while maintaining a Sector Perform rating.

Norwegian Cruise Line (NCLH) — JPMorgan Chase & Co. lowered its price target for the stock to $13.00 from $17.00 while maintaining a Neutral rating.

Norwegian Cruise Line (NCLH) — Truist Financial lowered its price target for the stock to $16.00 from $20.00 while maintaining a Hold rating.

Nuvectis Pharma (NVCT) — HC Wainwright reiterated its Buy rating on the stock with a price target of $39.00.

nVent Electric (NVT) — Wells Fargo & Company set a price target of $182.00 for the stock.

Okta (OKTA) — Bank of America raised its price target for the stock to $200.00 from $170.00 while maintaining a Neutral rating.

Okta (OKTA) — Barclays raised its price target for the stock to $215.00 from $180.00 while maintaining a Overweight rating.

Okta (OKTA) — BTIG Research reiterated its Buy rating on the stock with a price target of $219.00.

Okta (OKTA) — Citigroup reiterated its Neutral rating on the stock.

Okta (OKTA) — DA Davidson raised its price target for the stock to $235.00 from $190.00 while maintaining a Buy rating.

Okta (OKTA) — Evercore reiterated its Outperform rating on the stock with a price target of $240.00.

Okta (OKTA) — Guggenheim raised its price target for the stock to $227.00 from $188.00 while maintaining a Buy rating.

Okta (OKTA) — Jefferies Financial Group raised its price target for the stock to $240.00 from $200.00 while maintaining a Buy rating.

Okta (OKTA) — KeyCorp set a price target of $240.00 for the stock with an Overweight rating.

Okta (OKTA) — Mizuho raised its price target for the stock to $200.00 from $165.00 while maintaining a Neutral rating.

Okta (OKTA) — New Street Research set a price target of $235.00 for the stock.

Okta (OKTA) — Oppenheimer raised its price target for the stock to $227.00 from $190.00 while maintaining a Outperform rating.

Okta (OKTA) — Roth Capital raised its price target for the stock to $235.00 from $155.00 while maintaining a Buy rating.

Okta (OKTA) — Royal Bank Of Canada raised its price target for the stock to $230.00 from $195.00 while maintaining a Outperform rating.

Okta (OKTA) — Stifel Nicolaus raised its price target for the stock to $215.00 from $180.00 while maintaining a Buy rating.

Okta (OKTA) — TD Cowen raised its price target for the stock to $200.00 from $175.00 while maintaining a Hold rating.

Okta (OKTA) — Truist Financial set a price target of $235.00 for the stock.

Okta (OKTA) — Wells Fargo & Company raised its price target for the stock to $230.00 from $200.00 while maintaining a Overweight rating.

Old National Bancorp (ONB) — Wells Fargo initiated coverage of the company with an Overweight rating and a price target of $30.

ON (ONON) — Barclays raised its price target for the stock to $44.00 from $42.00 while maintaining a Overweight rating.

ON (ONON) — BMO Capital Markets raised its price target for the stock to $33.00 from $28.00 while maintaining a Market Perform rating.

ON (ONON) — Piper Sandler reiterated its Overweight rating on the stock with a price target of $45.00.

ON (ONON) — Sanford C. Bernstein reiterated its Outperform rating on the stock.

Oruka Therapeutics (ORKA) — HC Wainwright reiterated its Buy rating on the stock with a price target of $120.00.

Oruka Therapeutics (ORKA) — Wedbush reiterated its Outperform rating on the stock with a price target of $165.00.

Otis Worldwide (OTIS) — Wells Fargo & Company initiated coverage of the company with an Underweight rating and a price target of $77.00.

Parker-Hannifin (PH) — Wells Fargo & Company set a price target of $1,050.00 for the stock.

Paychex (PAYX) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $113 from $118.

Paychex (PAYX) — Jefferies Financial Group lowered its price target for the stock to $110.00 from $120.00 while maintaining a Hold rating.

Paychex (PAYX) — JP Morgan upgraded the stock from Underweight to Neutral and raised its price target to $115.00 from $105.00.

Paychex (PAYX) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $130.00.

Paychex (PAYX) — Stephens lowered its price target for the stock to $113.00 from $132.00 while maintaining a Equal Weight rating.

Paychex (PAYX) — Stifel Nicolaus lowered its price target for the stock to $112.00 from $130.00 while maintaining a Hold rating.

Paychex (PAYX) — UBS Group lowered its price target for the stock to $115.00 from $125.00 while maintaining a Neutral rating.

PepsiCo (PEP) — Citigroup reiterated its Neutral rating on the stock and lowered its price target to $142 from $145.

Permian Resources (PR) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $27.00.

Phillips Edison & Company, Inc. (PECO) — Mizuho lowered its price target for the stock to $39.00 from $43.00 while maintaining a Outperform rating.

Phillips Edison & Company, Inc. (PECO) — UBS Group set a price target of $39.00 for the stock.

Portland General Electric (POR) — KeyCorp reiterated its Sector Weight rating on the stock.

PPG Industries (PPG) — Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $136.00.

Praxis Precision Medicines (PRAX) — HC Wainwright reiterated its Buy rating on the stock with a price target of $1,201.00.

Praxis Precision Medicines (PRAX) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $582.00.

PubMatic (PUBM) — Craig Hallum initiated coverage of the company with a Buy rating and a price target of $24.

Quanta Services (PWR) — Bernstein upgraded the stock from Market Perform to Outperform and set a price target of $775.

Quanta Services (PWR) — Sanford C. Bernstein upgraded the stock from Market Perform to Outperform and raised its price target to $775.00 from $748.00.

Quince Therapeutics (QNCX) — Rodman & Renshaw initiated coverage of the company with a Buy rating and a price target of $70.

Regency Centers (REG) — JPMorgan Chase & Co. upgraded the stock from Neutral to Overweight and set a price target of $83.00.

Regency Centers (REG) — Mizuho lowered its price target for the stock to $76.00 from $82.00 while maintaining a Neutral rating.

Regency Centers (REG) — The Goldman Sachs Group set a price target of $83.00 for the stock.

Revolution Medicines (RVMD) — Goldman resumed coverage of the company with a Buy rating and a price target of $267.

Rockwell Automation (ROK) — Wells Fargo & Company set a price target of $426.00 for the stock.

Roivant Sciences (ROIV) — Cantor Fitzgerald reiterated its Overweight rating on the stock.

Roku (ROKU) — Wedbush reiterated its Neutral rating on the stock with a price target of $155.00.

Rollins (ROL) — Piper Sandler downgraded the stock from Overweight to Neutral and set a price target of $33.

Royal Caribbean Cruises (RCL) — JPMorgan Chase & Co. raised its price target for the stock to $394.00 from $345.00 while maintaining a Overweight rating.

Royal Caribbean Cruises (RCL) — Truist Financial raised its price target for the stock to $298.00 from $297.00 while maintaining a Hold rating.

Safehold (SAFE) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $14.

Sagimet Biosciences (SGMT) — Goldman resumed coverage of the company with a Sell rating and a price target of $7.

SailPoint (SAIL) — Truist Financial raised its price target for the stock to $27.00 from $23.00 while maintaining a Buy rating.

Scholar Rock (SRRK) — Truist Financial raised its price target for the stock to $77.00 from $76.00 while maintaining a Buy rating.

Sherwin-Williams (SHW) — Mizuho set a price target of $396.00 for the stock.

Shift4 Payments (FOUR) — Mizuho lowered its price target for the stock to $46.00 from $55.00 while maintaining a Outperform rating.

Shopify (SHOP) — Mizuho set a price target of $180.00 for the stock.

Solaris Energy Infrastructure (SEI) — Citigroup raised its price target for the stock to $100.00 from $84.00 while maintaining a Buy rating.

Solaris Energy Infrastructure (SEI) — Stifel Nicolaus raised its price target for the stock to $101.00 from $98.00 while maintaining a Buy rating.

Southwest Airlines (LUV) — UBS Group raised its price target for the stock to $53.00 from $49.00 while maintaining a Buy rating.

Spruce Biosciences (SPRB) — Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $144.00.

StandardAero (SARO) — Jefferies Financial Group set a price target of $25.00 for the stock.

Starwood Property Trust (STWD) — Citigroup reiterated its Market Outperform rating on the stock.

Stitch Fix (SFIX) — Northland Securities set a price target of $4.00 for the stock.

Stitch Fix (SFIX) — Sanford C. Bernstein reiterated its Market Perform rating on the stock with a price target of $4.00.

Stitch Fix (SFIX) — Telsey Advisory Group reiterated its Market Perform rating on the stock and lowered its price target to $3 from $5.

Stitch Fix (SFIX) — UBS Group lowered its price target for the stock to $3.50 from $4.00 while maintaining a Neutral rating.

Stitch Fix (SFIX) — William Blair downgraded the stock from Outperform to Market Perform.

Synopsys (SNPS) — BNP Paribas Exane upgraded the stock from Underperform to Neutral and set a price target of $420.

Tandem Diabetes Care (TNDM) — Truist Financial lowered its price target for the stock to $28.00 from $31.00 while maintaining a Buy rating.

Tanger Factory (SKT) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $39.

Tarsus Pharmaceuticals (TARS) — Goldman resumed coverage of the company with a Buy rating and a price target of $116.

Tesla (TSLA) — BNP Paribas Exane lowered its price target for the stock to $268.00 from $280.00 while maintaining a Underperform rating.

Tesla (TSLA) — UBS Group reiterated its Neutral rating on the stock.

Theravance Biopharma (TBPH) — BTIG Research reiterated its Neutral rating on the stock.

TransUnion (TRU) — UBS Group lowered its price target for the stock to $80.00 from $82.00 while maintaining a Neutral rating.

Travere Therapeutics (TVTX) — Guggenheim raised its price target for the stock to $89.00 from $75.00 while maintaining a Buy rating.

Twilio (TWLO) — HSBC downgraded the stock from Hold to Reduce and set a price target of $211.00.

Tyler Technologies (TYL) — BTIG Research reiterated its Buy rating on the stock with a price target of $400.00.

UiPath (PATH) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $15 from $18.

UiPath (PATH) — Canaccord Genuity Group lowered its price target for the stock to $14.00 from $17.00 while maintaining a Hold rating.

UiPath (PATH) — KeyCorp reiterated its Sector Weight rating on the stock.

UiPath (PATH) — New Street Research set a price target of $15.00 for the stock.

UL Solutions (ULS) — Robert W. Baird lowered its price target for the stock to $85.00 from $95.00 while maintaining a Outperform rating.

Union Pacific (UNP) — Royal Bank Of Canada set a price target of $326.00 for the stock.

United Airlines (UAL) — UBS Group raised its price target for the stock to $146.00 from $137.00 while maintaining a Buy rating.

United Rentals (URI) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $1,323.00.

United Therapeutics (UTHR) — Goldman initiated coverage of the company with a Sell rating and a price target of $321.

Vail Resorts (MTN) — Mizuho lowered its price target for the stock to $160.00 from $174.00 while maintaining a Outperform rating.

Vail Resorts (MTN) — Stifel Nicolaus lowered its price target for the stock to $161.00 from $167.00 while maintaining a Buy rating.

Versant (VSNT) — Citigroup initiated coverage of the company with a Buy rating and a price target of $41.

Vertiv (VRT) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $340.00.

VICI Properties (VICI) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $30.

VICI Properties (VICI) — Scotiabank lowered its price target for the stock to $26.00 from $29.00 while maintaining a Sector Perform rating.

Viking (VIK) — Truist Financial lowered its price target for the stock to $98.00 from $102.00 while maintaining a Buy rating.

W.P. Carey (WPC) — Scotiabank lowered its price target for the stock to $68.00 from $76.00 while maintaining a Sector Perform rating.

Welltower (WELL) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $260.

Western Union (WU) — Citigroup reiterated its Neutral rating on the stock.

WEX (WEX) — Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock.

Wintrust Fin (WTFC) — Wells Fargo initiated coverage of the company with an Equal Weight rating and a price target of $160.

Worthington Enterprises (WOR) — Canaccord Genuity Group raised its price target for the stock to $75.00 from $67.00 while maintaining a Buy rating.

Yum! Brands (YUM) — Argus downgraded the stock from Buy to Hold.

The post Analyst Updates: Sept 24, 2026 appeared first on Stock Target Advisor.